A Multicentre Randomised Trial Of Etanercept And Methotrexate To Induce Remission In Early Inflammatory Arthritis.
Phase of Trial: Phase IV
Latest Information Update: 19 Jan 2012
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Arthritis; Synovitis
- Focus Therapeutic Use
- Acronyms EMPIRE
- 10 Jun 2017 Biomarkers information updated
- 19 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 11 Jan 2012 New source identified and integrated (ISRCTN: Current Controlled Trials; ISRCTN55428162).